The global hospital acquired infections testing kits market size is expected to grow from $1.12 billion in 2021 to $1.27 billion in 2022 at a compound annual growth rate (CAGR) of 12.7%. The global hospital acquired infections testing kits market is expected to grow to $1.78 billion in 2026 at a CAGR of 8.8%.
What is the Global Hospital Acquired Infections Testing Kits Market?
The hospital-acquired infections testing kits market consists of sales of hospital-acquired infections testing kits, devices, and related services. Hospital-acquired infections testing kits are used to check the infections associated with pathogens such as vancomycin-resistant enterococci (VRE), methicillin-resistant staphylococcus aureus (MRSA), multi-resistant gram-negative bacilli, norovirus, and clostridium difficile.
Get a Sample of the global hospital acquired infections testing kits market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp
What drives the Global Hospital Acquired Infections Testing Kits Market?
The hospital-acquired infections (HAIs) are on the rise, affecting both the inpatients and outpatients. Hospital-acquired infections or nosocomial infections are diseases that are acquired in hospitals and medical clinics. For example, according to the findings by the Center for Disease Control and Prevention, around 1.7 million people in the USA acquire hospital-acquired infections caused while being admitted for other health issues and more than 98,000 (around 5%) patients die due to these infections. The increasing incidence of hospital-acquired infections leads to an increase in the demand for hospital-acquired infections testing kits.
Get the full global hospital acquired infections testing kits industry report here
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report
Global Hospital Acquired Infections Testing Kits Market Segments
The global hospital acquired infections testing kits market is segmented:
By Product: Instrument and Reagents, Consumables
By Test Type: Pneumonia Infection, Urinary Tract Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA Infection, Others
By Application: Drug-Resistance Testing, Disease Testing
By Pathogen Type: Viral, Bacterial, Fungal
By Method of Treatment: Sterilization, Chemical, Radiation
By Geography: The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Hospital Acquired Infections Testing Kits Global Market Report 2022provides market size and growth forecasts for the global hospital acquired infections testing kits market, global hospital acquired infections testing kits market share, hospital acquired infections testing kits market segments and geographies, hospital acquired infections testing kits market competitive landscape including leading competitors’ revenues, profiles and market shares. The hospital acquired infections testing kits market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Hospital Acquired Infections Testing Kits Industry Playersinclude Becton, Dickinson and Company, Abott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Roche, Bayer AG, Cantel Medical Corporation, and Meridian Bioscience. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
